Your browser doesn't support javascript.
loading
Evolving landscape of PD-L2: bring new light to checkpoint immunotherapy.
Wang, Yuqing; Du, Jiang; Gao, Zhenyue; Sun, Haoyang; Mei, Mei; Wang, Yu; Ren, Yu; Zhou, Xuan.
Affiliation
  • Wang Y; Department of Maxillofacial and Otorhinolaryngological Oncology, Tianjin Medical University Cancer Institute and Hospital; Key Laboratory of Cancer Prevention and Therapy, Tianjin Cancer Institute; National Clinical Research Center of Cancer, 300060, Tianjin, China.
  • Du J; Department of Cell Biology, School of Basic Medical Sciences, Tianjin Medical University, 300070, Tianjin, China.
  • Gao Z; Department of Maxillofacial and Otorhinolaryngological Oncology, Tianjin Medical University Cancer Institute and Hospital; Key Laboratory of Cancer Prevention and Therapy, Tianjin Cancer Institute; National Clinical Research Center of Cancer, 300060, Tianjin, China.
  • Sun H; Department of Cell Biology, School of Basic Medical Sciences, Tianjin Medical University, 300070, Tianjin, China.
  • Mei M; Department of Genetics, School of Basic Medical Sciences, Tianjin Medical University, 300070, Tianjin, China.
  • Wang Y; Department of Cell Biology, School of Basic Medical Sciences, Tianjin Medical University, 300070, Tianjin, China.
  • Ren Y; Department of Maxillofacial and Otorhinolaryngological Oncology, Tianjin Medical University Cancer Institute and Hospital; Key Laboratory of Cancer Prevention and Therapy, Tianjin Cancer Institute; National Clinical Research Center of Cancer, 300060, Tianjin, China. wangyu1991@tmu.edu.cn.
  • Zhou X; Department of Genetics, School of Basic Medical Sciences, Tianjin Medical University, 300070, Tianjin, China. yuren0925@tmu.edu.cn.
Br J Cancer ; 128(7): 1196-1207, 2023 03.
Article in En | MEDLINE | ID: mdl-36522474

Full text: 1 Database: MEDLINE Main subject: Head and Neck Neoplasms / Immunotherapy Type of study: Prognostic_studies Limits: Humans Language: En Year: 2023 Type: Article

Full text: 1 Database: MEDLINE Main subject: Head and Neck Neoplasms / Immunotherapy Type of study: Prognostic_studies Limits: Humans Language: En Year: 2023 Type: Article